Sodium Chloride eye drops 5 percent, 5 ml bott,Sodium Hyluronate opthalmic sol 14mgml, PFS,Lulicona
Dg Armed Forces Medical Service
Bid Publish Date
19-May-2025, 4:27 pm
Bid End Date
09-Jun-2025, 5:00 pm
Location
Progress
RAQuantity
19998
Category
eye drop Lotepredenol etabonate 0.5pct bott of 5 ml
Bid Type
Two Packet Bid
Public procurement opportunity for Indian Army eye drop Lotepredenol etabonate 0. 5pct bott of 5 ml, Lignocaine 1pct for intra ocular use vial of 1 ml preservative free, Inj Lignocaine Intracam 0. 05pct vial 1ml, Eye Drop Natamycin 3pct bott of 3ml, Pilocarpine Nitrate Sol 2pct bott of 5ml, Pilocarpine Intracameral Inj 0. 5pct without preservatives amp of 01ml each, Eye drop Povidone 5pct eye drop bott of 5 ml, Eye Drop Prednisolone Acetate 1pct wv bott of 5ml, Sodium Chromoglycate eye drops 2pct bott of 5 ml, Sodium Chloride 6pct ointment Tube of 3 gm, Sodium Chloride eye drops 5pct bott of 5 ml, Timolol Maleate eye drop 0. 5pct bott of 5 ml, Tobramycin 0. 3pct bott of 5 ml, Tropicamide 1pct with 5pct Phenylephrine eye drops bott of 5ml, Tropicamide eye solution 1pct bott 5ml, Eye Oint Atropine sulphate oint 1pct Tube of 3 gm, Dexamethasone Eye Drop 0. 1pct Bott Of 5 ml, Eye Oint Dexamethasone 0. 1pct with Tobramycin 0. 3pct tube 3. 5 gm, Bimatoprost 0. 03pct bott of 3ml, Eye drop Dorzolamide2pct with Timolol Maleate 0. 5pct, Olopatadine Hydrochloride 0. 2pct Opthalmic soln bott of 5ml, moxifloxacin hcl 0. 5pct with dexamethasone 0. 1pct opthalmic soln bott of 5ml, Cinnarizine 25 mg Tab in MEERUT, UTTAR PRADESH. Quantity: 19998 issued by. Submission Deadline: 09-06-2025 17: 00: 00. View full details and respond.
Main Document
BOQ
BOQ
ATC
GEM_GENERAL_TERMS_AND_CONDITIONS
Dg Armed Forces Medical Service
Indian Army
HYDERABAD, TELANGANA
Indian Army
HYDERABAD, TELANGANA
Dg Armed Forces Medical Service
Indian Army
Tender Results
Loading results...
| Item # | Title | Description | Quantity | Unit | Consignee | Delivery (Days) |
|---|---|---|---|---|---|---|
| 1 | eye drop Lotepredenol etabonate 0.5pct bott of 5 ml | As per item title | 1,230 | bott | [email protected] | 21 |
| 2 | Lignocaine 1pct for intra ocular use vial of 1 ml preservative free | As per item title | 120 | vial | [email protected] | 21 |
| 3 | Inj Lignocaine Intracam 0.05pct vial 1ml | As per item title | 180 | vial | [email protected] | 21 |
| 4 | Eye Drop Natamycin 3pct bott of 3ml | As per item title | 360 | bott | [email protected] | 21 |
| 5 | Pilocarpine Nitrate Sol 2pct bott of 5ml | As per item title | 60 | bott | [email protected] | 21 |
| 6 | Pilocarpine Intracameral Inj 0.5pct without preservatives amp of 01ml each | As per item title | 180 | amp | [email protected] | 21 |
| 7 | Eye drop Povidone 5pct eye drop bott of 5 ml | As per item title | 790 | bott | [email protected] | 21 |
| 8 | Eye Drop Prednisolone Acetate 1pct wv bott of 5ml | As per item title | 890 | bott | [email protected] | 21 |
| 9 | Sodium Chromoglycate eye drops 2pct bott of 5 ml | As per item title | 1,200 | bott | [email protected] | 21 |
| 10 | Sodium Chloride 6pct ointment Tube of 3 gm | As per item title | 360 | tube | [email protected] | 21 |
| 11 | Sodium Chloride eye drops 5pct bott of 5 ml | As per item title | 990 | bott | [email protected] | 21 |
| 12 | Timolol Maleate eye drop 0.5pct bott of 5 ml | As per item title | 480 | bott | [email protected] | 21 |
| 13 | Tobramycin 0.3pct bott of 5 ml | As per item title | 850 | bott | [email protected] | 21 |
| 14 | Tropicamide 1pct with 5pct Phenylephrine eye drops bott of 5ml | As per item title | 220 | bott | [email protected] | 21 |
| 15 | Tropicamide eye solution 1pct bott 5ml | As per item title | 66 | bott | [email protected] | 21 |
| 16 | Eye Oint Atropine sulphate oint 1pct Tube of 3 gm | As per item title | 150 | tube | [email protected] | 21 |
| 17 | Dexamethasone Eye Drop 0.1pct Bott Of 5 ml | As per item title | 72 | bottle | [email protected] | 21 |
| 18 | Eye Oint Dexamethasone 0.1pct with Tobramycin 0.3pct tube 3.5 gm | As per item title | 190 | tube | [email protected] | 21 |
| 19 | Bimatoprost 0.03pct bott of 3ml | As per item title | 300 | bott | [email protected] | 21 |
| 20 | Eye drop Dorzolamide2pct with Timolol Maleate 0.5pct | As per item title | 300 | bott | [email protected] | 21 |
| 21 | Olopatadine Hydrochloride 0.2pct Opthalmic soln bott of 5ml | As per item title | 3,000 | bott | [email protected] | 21 |
| 22 | moxifloxacin hcl 0.5pct with dexamethasone 0.1pct opthalmic soln bott of 5ml | As per item title | 3,310 | bott | [email protected] | 21 |
| 23 | Cinnarizine 25 mg Tab | As per item title | 4,700 | no | [email protected] | 21 |
Experience Criteria
Past Performance
Certificate (Requested in ATC)
OEM Authorization Certificate
Compliance of BoQ specification and supporting document *In case any bidder is seeking exemption from Experience / Turnover Criteria
the supporting documents to prove his eligibility for exemption must be uploaded for evaluation by the buyer
Start
28-Jul-2025, 3:00 pm
End
29-Jul-2025, 3:00 pm
Duration: 24 hours
Reverse Auction Document
✅ RA concluded. Check financial results for final rankings.
| S.No | Seller | Item | Date | Status |
|---|---|---|---|---|
| 1 | ********** Under PMA | - | 09-06-2025 16:54:39 | Evaluated |
| 2 | ********** Under PMA | - | 06-06-2025 16:34:43 | Evaluated |
| 3 | ********** Under PMA | - | 09-06-2025 15:11:28 | Evaluated |
| 4 | ********** Under PMA | - | 07-06-2025 19:18:27 | Evaluated |
| 5 | ********** Under PMA | - | 07-06-2025 14:46:22 | Evaluated |
| 6 | ********** Under PMA | - | 07-06-2025 19:26:34 | Evaluated |
| 7 | ********** Under PMA | - | 04-06-2025 14:10:31 | Evaluated |
| 8 | ********** Under PMA | - | 31-05-2025 17:29:40 | Evaluated |
| 9 | ********** Under PMA | - | 09-06-2025 13:19:18 | Evaluated |
| 10 | ********** Under PMA | - | 06-06-2025 12:21:54 | Evaluated |
| 11 | ********** Under PMA | - | 23-05-2025 16:21:40 | Evaluated |
| 12 | ********** Under PMA | - | 08-06-2025 15:01:45 | Evaluated |
| 13 | ********** Under PMA | - | 07-06-2025 23:06:53 | Evaluated |
| 14 | ********** Under PMA | - | 07-06-2025 15:34:28 | Evaluated |
| 15 | ********** Under PMA | - | 31-05-2025 13:08:22 | Evaluated |
| 16 | ********** Under PMA | - | 09-06-2025 13:10:14 | Evaluated |
| 17 | ********** Under PMA | - | 06-06-2025 11:34:46 | Evaluated |
| 18 | ********** Under PMA | - | 07-06-2025 16:45:28 | Evaluated |
| 19 | ********** Under PMA | - | 09-06-2025 11:56:33 | Evaluated |
Key insights about UTTAR PRADESH tender market
The eligibility requirements include being a registered entity with proper licenses to manufacture or distribute pharmaceutical products. Bidders should demonstrate compliance with industry regulations and must be able to submit documentation validating their capabilities.
Bidders must provide several required certificates demonstrating that their products meet safety and efficacy standards. This typically includes manufacturing licenses, quality assurance certificates, and compliance with local health regulations. Documents ensuring appropriate testing criteria must be available upon request.
The registration process entails creating an account on the designated electronic platform, followed by the submission of relevant documentation as outlined in the tender. Bidders are encouraged to review the guidelines thoroughly to ensure all necessary paperwork is prepared and submitted correctly.
The accepted document formats include PDF, DOCX, and other standard file types that can be easily accessed. Bidders should confirm the specifics as detailed in the tender document to ensure that submissions adhere to predefined requirements.
MSEs stand to gain significant benefits including reduced Earnest Money Deposit (EMD) requirements, simplified documentation processes, and encouragement of local procurement policies under the 'Make in India' initiative. These provisions enhance opportunities for small enterprises to participate in government procurement contracts effectively.
Sign up now to access all documents
Main Document
BOQ
BOQ
ATC
GEM_GENERAL_TERMS_AND_CONDITIONS